Early Cancer Detection Could Save Your Life
Discover our non-invasive approach that turns a single biological sample into life-saving data. We deliver highly accurate, rapid, and cost-effective cancer diagnostics—without radiation or invasive procedures.
About Us Contact Us
Blood
Our blood tests identify the genetic profiles of cancer cells, known as circulating tumor DNA (ctDNA). This data can be used to confirm the presence of more than 50 types of cancer and to identify genetic alterations that are helpful in selecting treatment options. We further implement Protein-Based Blood Tests to identify proteins that are released by cancer cells. A well-known example is the PSA test (prostate specific antigen) used in the diagnosis of prostate cancer.
Learn MoreUrine
We provide a urine test that can reliably detect, monitor, and predict the risk of urothelial cancers (such as bladder, kidney, ureter, and urethral cancers) as well as prostate cancer, well before signs and symptoms become detectable by historical standards of care. Our testing interrogates 60 of the most high-impact urothelial cancer genes and has also been validated to determine minimal residual disease (MRD) in patients with a history of bladder cancer.
Learn MoreFecal
Colorectal cancer (CRC) is the third most commonly diagnosed cancer and the second most common cause of cancer-related death in both men and women in the United States. Our FDA-approved fecal test is designed to detect this life-threatening disease early, by harnesses the power of RNA biomarkers.
Learn MoreBreath
By way of analyses of volatile organic compounds (VOCs), a single exhale can unlock cancer data. Our breath diagnostics identify a variety of cancers (such as lung, breast, colorectal, prostate, liver, and pancreatic cancers) with unmatched accuracy, non-invasive screening, and life-saving insights.
Learn More
About Early Cancer Detection
In recent years, significant progress has been made in the development of testing for cancer diagnosis. These tests are often referred to as “biological biopsies” as they can be used to detect cancers and provide a better understanding about them by looking for biomarkers in biological materials, such as breath, urine, feces, and blood. Our tests are evaluated in multiple peer-reviewed publications as well as FDA-approved.
For comfort and convenience, samples are acquired at home and delivered by team members to a lab. For maximum assurance, all four tests should be conducted annually.
About Us
At Kiva, we leverage state-of-the-art technology, including liquid biopsy and advanced biomarker analysis, to identify potential signs of cancer at the earliest and most treatable stages — without radiation or invasive procedures. Our mission is to empower individuals with the tools they need for detecting cancer before symptoms appear, enabling them to take proactive steps toward maintaining their health by staying ahead of the disease. We continuously push the boundaries to offer a smarter, more effective approach to making early cancer detection a routine part of everyone’s healthcare journey.
Let us help you take control of your health. With Kiva, you’re not just screening for cancer — you’re investing in your future.
A trusted partner to the best
-
“We’ve been using Stack to prototype designs quickly and efficiently. Needless to say we’re hugely impressed by the style and value.”Maguerite Holland
Interface Designer — Yoke -
“I've been using Medium Rare's templates for a couple of years now and Stack is without a doubt their best work yet. It's fast, performant and absolutely stunning.”Lucas Nguyen
Freelance Designer -
“Variant has been a massive plus for my workflow — I can now get live mockups out in a matter of hours, my clients really love it.”Rob Vasquez
Interface Designer — Yoke
